Diabetes Update: Beyond Glycemic Management – Nurse Practitioner

  Price  

  Credits  

This product is currently out of stock and unavailable.


Format
In 2021, insulin will celebrate its 100th anniversary. Yet a century after the discovery of insulin, the US is experiencing an escalation in the number of diabetes cases. In 2020, the Center for Disease Control and Prevention (CDC) reported that 34.2 million Americans (11% of the US population) have diabetes and 88 million American adults (35% of the US adult population) have prediabetes. New diabetes cases were higher among non-Hispanic blacks and people of Hispanic origin. Additionally, racial and ethnic minorities continue to develop type 2 diabetes at higher rates. The occurrence of diagnosed diabetes was highest among American Indians and Alaska Natives (14.7%), followed by people of Hispanic origin (12.5%), non-Hispanic blacks (11.7%), non-Hispanic Asians (9.2%) and non-Hispanic whites (7.5%). Coupled with the rising prevalence of diabetes is the obesity epidemic. Obesity is defined as a body mass index (BMI) greater than or equal to 30 kg/m; severe obesity is a BMI greater than or equal to 40 kg/m2. In 2017–2018, 42% of adults in the US were considered obese. By age group, the incidence was 40% for 20 - 39 year old adults; nearly 45% for 40 - 59 year old adults; and nearly 43% among adults 60 years and older. Both obesity and severe obesity were highest in non-Hispanic black adults and higher among women than men.

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Nurse Practitioner

Author

Brian T. Cryder
PharmD, CACP, BCACP
Susan Cornell
PharmD, CDCES, FAPhA
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Course Accreditation

  • Activity Type:
    Application
  • CE Broker
    868627
  • Universal Activity Number:
    Nurse Practitioner : 0798-0000-21-183-H01
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.